drugset / Trial / NCT00218283

Nicotine Lozenge to Reduce Smokeless Tobacco Use

NCT00218283

RandomizedParallel-groupOpen-labelTreatment

Summary

Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has as many health risks associated with its use as cigarettes. While there are many treatment programs that focus on stopping tobacco use, there are no interventions that specifically focus on reducing tobacco use. This study will evaluate the effectiveness of nicotine lozenge at reducing tobacco use in ST users.

Timeline

Start
2005-01
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown Oral

Indications